AR and prostate cancer: Cell proliferation studies suggested that AR levels might influence the ability of prostate cancer cells to respond to metformin, for the AR-negative PC-3 cells were less sensitive to the anti-tumor effects of metformin than the AR-positive C4–2 and 22Rv1 cells.